Metrics as of 10/16/2026, 08:49 AM (Berlin time), refresh in progress.
Canopy Growth Stock
Canopy Growth Corporation
Company data
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Country
- Canada
- CEO
- Luc Mongeau
- Employees
- 1,128
- Market cap
- $302 M
- IPO
- 07/04/2014
Canopy Growth Corporation (CGC), alongside its affiliated businesses, specializes in the cultivation, marketing, and retail of both cannabis and hemp-derived products. These offerings are designed for both recreational consumption and therapeutic uses, with its primary commercial reach extending across Canada, the…
Canopy Growth stock: price history
1D
-3.1%
1W
-13.8%
1M
-22.1%
6M
-37.5%
YTD
-37.5%
1Y
-47.2%
2Y
-83.3%
5Y
-99.5%
10Y
-98.3%
Next earnings date
Next earnings date
06/11/2026 (in 20 days)
Volatility around earnings
~50% stronger price swings than usual
Ask the agents about Canopy Growth
Analyst assessment of Canopy Growth
PRICE TARGET LOW
US$8.00
CONSENSUS
US$14.47
MEDIAN
US$11.02
PRICE TARGET HIGH
US$27.85
0
STRONG BUY
9
BUY
11
HOLD
7
SELL
0
STRONG SELL
27
TOTAL · Hold
As of: 10/11/2025
Canopy Growth stock metrics
P/E
-1.5
P/B
0.61
EV/EBITDA
-11.59
RETURN ON EQUITY
-2.1%
NET MARGIN
-18.0%
DEBT/EQUITY
0.4
DIVIDEND YIELD
0.0%
AS OF
30/06/2026
Free float & liquidity
FREE FLOAT
99.4%
FLOAT SHARES
420,663,065
AVG. DAILY VOLUME (30D)
2,462,943
Insider transactions (SEC)
Lazzarato David Angelo
BAYERN JOSEPH
ATKINS M SHAN
Yanofsky Theresa
Stewart Thomas Carlton
Attention
1 mention today in US forums, about the same as yesterdayPrice since yesterday: -3.1%
Forums (Reddit)
Institutional holders
Dividends & Stock splits
Comparable stocks
Frequently asked questions about Canopy Growth stock
What does Canopy Growth do?
Canopy Growth Corporation is a company in the Healthcare sector, Drug Manufacturers - Specialty & Generic industry, headquartered in Canada.
The CEO is Luc Mongeau, the company employs around 1,128 people.
The IPO was on 07/04/2014; the stock trades on NASDAQ under the ticker CGC.
What do analysts say about Canopy Growth stock?
27 analysts rate the stock, the consensus is Hold (as of 10/11/2025).
The average price target is US$14.47, ranging from US$8.00 to US$27.85, with a median of US$11.02.
This is an external assessment, not a statement by Market Jury.
When does Canopy Growth report next?
The next earnings date is 06/11/2026.
Around past earnings, price swings were roughly 50% stronger than usual.
Does Canopy Growth pay a dividend?
No, Canopy Growth currently does not pay a dividend.
Which stocks are comparable to Canopy Growth?
Comparable stocks include Merck, Takeda Pharmaceutical Company, Teva Pharmaceutical Industries, Zoetis, Sandoz Group, Viatris, Lantheus Holdings and Amneal Pharmaceuticals.
How can I get Canopy Growth stock analyzed?
Clicking "Analyze stock" lets five strategies assess Canopy Growth against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.